Article Versions Notes

Lopalco A, Manni A, Keeley A, Haider S, Li W, Lopedota A, Altomare CD, Denora N, Tuleu C. In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics. 2022; 14(4):780. https://doi.org/10.3390/pharmaceutics14040780

Lopalco, Antonio, Annachiara Manni, Alexander Keeley, Shozeb Haider, Wenliang Li, Angela Lopedota, Cosimo Damiano Altomare, Nunzio Denora, and Catherine Tuleu. 2022. "In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use" Pharmaceutics 14, no. 4: 780. https://doi.org/10.3390/pharmaceutics14040780

Lopalco, A., Manni, A., Keeley, A., Haider, S., Li, W., Lopedota, A., Altomare, C. D., Denora, N., & Tuleu, C. (2022). In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics, 14(4), 780. https://doi.org/10.3390/pharmaceutics14040780